946 Shares in CME Group Inc. (NASDAQ:CME) Acquired by MFA Wealth Services

MFA Wealth Services bought a new stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 946 shares of the financial services provider’s stock, valued at approximately $220,000.

A number of other hedge funds also recently modified their holdings of the business. Truvestments Capital LLC purchased a new position in CME Group during the third quarter valued at approximately $26,000. Dunhill Financial LLC grew its holdings in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 81 shares in the last quarter. Fortitude Family Office LLC increased its stake in shares of CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 83 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares in the last quarter. Finally, Avior Wealth Management LLC boosted its position in CME Group by 51.6% during the fourth quarter. Avior Wealth Management LLC now owns 329 shares of the financial services provider’s stock valued at $76,000 after purchasing an additional 112 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In other news, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the transaction, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. This represents a 8.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,274 shares of company stock worth $1,648,071. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $233.38 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $84.10 billion, a P/E ratio of 24.54, a P/E/G ratio of 5.28 and a beta of 0.56. The business’s 50 day moving average is $233.64 and its two-hundred day moving average is $220.69.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.25 EPS. On average, equities analysts expect that CME Group Inc. will post 10.18 EPS for the current year.

CME Group announced that its board has authorized a stock repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

CME Group Increases Dividend

The business also recently disclosed a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were given a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is a positive change from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio is currently 48.37%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Bank of America raised their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Barclays raised their price target on shares of CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a report on Monday, December 9th. Finally, TD Cowen initiated coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $229.27.

Get Our Latest Stock Report on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.